4//SEC Filing
Gagnon Robert E. 4
Accession 0001641172-25-014098
CIK 0001419554other
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 5:01 PM ET
Size
9.6 KB
Accession
0001641172-25-014098
Insider Transaction Report
Form 4
Gagnon Robert E.
Director
Transactions
- Award
Non-Employee Stock Option
2025-06-04+62,894→ 62,894 totalExercise: $0.88Exp: 2035-06-04→ Common Stock (62,894 underlying)
Holdings
- 8,006
Non-Employee Stock Option
Exercise: $4.68Exp: 2034-01-08→ Common Stock (8,006 underlying) - 30,713
Non-Employee Stock Option
Exercise: $1.73Exp: 2034-09-17→ Common Stock (30,713 underlying) - 9
Non-Employee Stock Option
Exercise: $4.68Exp: 2034-01-08→ Common Stock (9 underlying)
Footnotes (3)
- [F1]This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests in four equal quarterly installments.
- [F2]This option was granted on 9/17/2024 and vests in four equal quarterly installments.
- [F3]This option is fully exercisable as of the date of this report.
Documents
Issuer
Bone Biologics Corp
CIK 0001419554
Entity typeother
Related Parties
1- filerCIK 0001504983
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 5:01 PM ET
- Size
- 9.6 KB